Brooktree Capital Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.1M	Sell	4,372 -787	-15%	-$196K	0.87%	22
2025 Q4	$1.42M	Sell	5,159 -140	-3%	-$38.3K	0.94%	19
2025 Q3	$1.39M	Buy	5,299 +374	+8%	+$90.9K	0.88%	19
2025 Q2	$1.08M	Buy	4,925 +185	+4%	+$39.5K	0.7%	21
2025 Q1	$1.06M	Buy	4,740 +154	+3%	+$42.4K	0.8%	19
2024 Q4	$1.5M	Sell	4,586 -18	-0.4%	-$5.67K	1.11%	18
2024 Q3	$1.38M	Buy	4,604 +139	+3%	+$42.6K	1.12%	20
2024 Q2	$1.47M	Sell	4,465 -198	-4%	-$70K	1.26%	19
2024 Q1	$1.85M	Buy	4,663 +187	+4%	+$69.2K	1.42%	19
2023 Q4	$1.58M	Sell	4,476 -265	-6%	-$93.8K	1.27%	20
2023 Q3	$1.78M	Buy	4,741 +141	+3%	+$54.5K	1.49%	20
2023 Q2	$1.76M	Sell	4,600 -400	-8%	-$143K	1.34%	19
2023 Q1	$1.73M	Buy	5,000 +788	+19%	+$230K	1.35%	18
2022 Q4	$991K	Buy	4,212 +68	+2%	+$16.1K	0.81%	22
2022 Q3	$1.02M	Buy	4,144 +384	+10%	+$117K	0.84%	24
2022 Q2	$1.14M	Buy	3,760 +615	+20%	+$200K	0.85%	24
2022 Q1	$1.29M	Buy	+3,145	New	+$1.23M	0.84%	25